Joseph R. Strelnik

FDA investigator

Appears on 13 documents from 2011 to 2022, mostly at sites in Indiana. Most often cites design controls (21 CFR 820.30).

13
Documents on file
4.8
Observations per 483
2011
First seen
2022
Most recent

What they cite most

From 63 observations

Activity by year

2011: 1, 2013: 1, 2015: 2, 2016: 4, 2017: 1, 2018: 1, 2019: 2, 2022: 1

Where

Indiana 11 · Missouri 1 · South Korea 1

Is Joseph R. Strelnik coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Kimball Electronics Indianapolis, Inc.Feb 24, 2022 · Indianapolis, Indiana
483 Meridian Medical Technologies, LLCDec 21, 2019 · St. Louis, Missouri
483 Biomedix WAIOct 31, 2019 · Bloomington, Indiana
483 Hanmi Pharm. Co., Ltd.Feb 1, 2018 · Pyeongtaek, South Korea
483 Zimmer Biomet, Inc.Oct 16, 2017 · Warsaw, Indiana
483 Zimmer Biomet, Inc.Nov 22, 2016 · Warsaw, Indiana
483 Roche Diagnostics Operations, IncAug 15, 2016 · Indianapolis, Indiana

About this profile

What does Joseph R. Strelnik inspect?

Joseph R. Strelnik appears on 13 documents on file covering 13 sites, mostly in Indiana.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 820.70 and 21 CFR 820.75(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Joseph R. Strelnik is dated Feb 24, 2022.